Both Tirzepatide and Mounjaro represent new approaches to managing type 2 diabetes, and increasingly, obesity. Semaglutide is a combined molecule that impacts several hormones involved in glucose regulation: this peptide and GIP. Mounjaro, often seen as a trade name for Tirzepatide, functions sim